scispace - formally typeset
H

Hugo Gorissen

Researcher at Eli Lilly and Company

Publications -  8
Citations -  40

Hugo Gorissen is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Benzopyran & Ring (chemistry). The author has an hindex of 3, co-authored 8 publications receiving 38 citations.

Papers
More filters
Journal ArticleDOI

Novel approaches towards the LTD4/E4 antagonist, LY290154

TL;DR: Several novel approaches have been investigated for the synthesis of the LTD4/E-4 antagonist LY290154 as mentioned in this paper, and an asymmetric synthesis offering significant advantages over the enantioselective route reported by McKillop was demonstrated.
Journal ArticleDOI

The ring opening of 3,4-dichloro-1,2,5-thiadiazole with metal amides. A new synthesis of 3,4-disubstituted-1,2,5-thiadiazoles

TL;DR: In this paper, a new synthesis of 3,4-disubstituted 1,2,5-thiadiazoles was developed based on the ring opening of readily available 3, 4-dichloro-1, 2, 5thiadiadiazole with metal amides to afford a stable synthon.
Journal ArticleDOI

The palladium-catalyzed cross-coupling reactions of 3-chloro-4-halogeno-1,2,5-thiadiazoles

Alain Merschaert, +1 more
- 01 Jan 2003 - 
TL;DR: In this article, the problem of side-reactions resulting from the concurrent decomposition of the heterocyclic ring of the starting material is resolved by involving, in these Pd-catalyzed cross-coupling reactions, the more reactive and selective 3-bromo-4-chloro- and 3-chloroniodo-1,2,5-thiadiazole.
Patent

Method for resolving chiral (2s) and (2r) chromanes

TL;DR: In this article, processes for resolving chiral (2S and (2R) benzopyrans, racemizing (1R) and recycling (2C) racemized benzoprinear agents to increase yield of a desired enantiomer to provide purified or substantially purified bicyclic amino substituted benzopyan derivatives are discussed.
Patent

Process for the preparation of benzoyl substituted bicyclic compounds and chiral benzopyran derivatives

TL;DR: In this article, processes for coupling amino substituted 2-chromanyl derivatives and benzoyl derivatives via an amide bond, and intermediates for producing platelet aggregation inhibitors were discussed.